Thromboembolic phenomena and the use of the pig as an appropriate animal model for research on cardiovascular devices

International Journal of Artificial Organs

Volumn 20, Issue 4, 1997, Pages 195-203

  Gross, D R ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CARDIOVASCULAR DEVICES;

ANGIOTENSIN; BLOOD CLOTTING FACTOR; CALCIUM ION; CISPLATIN; INTERLEUKIN 8; NITRIC OXIDE; OXYGEN RADICAL; PHOSPHATIDYLINOSITOL KINASE; PROSTAGLANDIN E2; PROTEASE NEXIN; PROTEINASE; SODIUM SELENITE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE;

ANIMAL MODEL; BLOOD CLOTTING; BLOOD FLOW; BLOOD VESSEL INJURY; BLOOD VESSEL PROSTHESIS; CARDIOVASCULAR EQUIPMENT; CELL INTERACTION; FIBRINOLYSIS; HUMAN; LEUKOCYTE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SWINE; THROMBOCYTE; THROMBOEMBOLISM; THROMBOGENICITY; VASCULAR ENDOTHELIUM;

EID: 0030952184     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702000402     Document Type: Review

References (89)

1. de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoieses by the c-Mpl ligand. Nature 1994; 369:533-8.
2. Wachowicz B, Krajewski T, Olas B, Zbikowska HM. Effects of cisplatin and selenite on the level of thiols in pig blood platelets. J Physiol Pharmacol 1995; 46: 97-103.
3. Wachowicz B. Inhibitory effect of cisplatin on the enzymatic peroxidation of platelet endogenous arachidonate. Cytobios 1993; 75: 157-62.
4. Tohyama Y, Yanagi S, Sada K, Yamamura H. Translocation of p72syk to the cytoskeleton in thrombin-stimulated platelets. J Biol Chem 1994; 269: 32796-9.
5. Yanagi S, Sada K, Tohyama Y, et al. Translocation, activation and association of protein-tyrosine kinase (p72syk) with phosphatidylinositol 3-kinase are early events during platelet activation. Eur J Biochem 1994; 224: 329-33.
6. Wang X, Sada K, Yanagi S, et al. Intracellular calcium dependent activation of p72syk in platelets. J Biochem (Tokyo) 1994; 116: 858-61.
7. Ding KH, Liang NC. inhibition of 5'-chloro-5'-deoxyadenosine on phosphoinositide and protein phosphorylation in swine platelets. Chung Kuo Yao Li Hsueh Pao 1995; 16:247-50.
8. Schmaier AH, Dahl LD, Rosemuller AJ, et al. Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IX a. J Clin Invest 1993; 92: 2540-5.
9. Eitzman DT, Chi L, Saggin L, et al. Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4. Circulation 1994; 89: 1523-9
10. Fujii C, Yanagi S, Sada K, et al. Involvement of protein-tyrosine kinase p72syk in collagen-induced signal transduction in platelet. Eur J Biochem 1994; 226: 243-8.
11. Rezaul K, Yanagi S, Sada K, Taniguchi T, Yamamura H; Protein-tyrosine kinase p72syk is activated by platelet activating factor in platelets. Thromb Haemost 1994; 72: 937-41.
12. Sada K, Yanagi S, Yamamura H. Activation of p72syk by thrombin in a cell-free system. Biochem Biophys Res Commun 1994; 200: 1-7.
13. 2+ mobilization in platelets. J Biol Chem 1993; 268: 2277-9.
14. 2+ mobilization in human platelets. Anesthesiology 1993; 78: 733-43.
15. Naraba H, Imai Y, Hayashi M, Oh-ishi S. Enhanced production of platelet-activating factor in stimulated rat leukocytes caused by the blockade of lysophospholipid acylation. Jpn J Pharmacol 1993; 61: 109-13.
16. Kaul S, Padgett RC, Heistand DD. Role of platelets and leukocytes in modulation of vascular tone. Ann NY Acad Sci 1994; 714: 122-35.
17. Bradbury AW, Murie JA, Ruckley CV. Role of the leucocyte in the pathogenesis of vascular disease. Br J Surg 1993; 80: 1503-12.
18. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994; 66: 14-7.
19. Knight JA, Searles DA, Blaylock RC. Lipid peroxidation in platelet concentrates: effects of leukocyte removal by filtration. Ann Clin Lab Sci 1994; 24: 69-75.
20. Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest 1994; 93: 2073-83.
21. Kirchhofer D, Sakariassen KS, Clozel M, et al; Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions; Blood 1993; 81: 2050-8.
22. Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 1993; 87: 590-7.
23. Kanwar S, Woodman RC, Poon MC, et al. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood 1995; 86: 2760-6.
24. Lehr HA, Olofsson AM, Carew TW, et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994; 71: 380-6.
25. Gibson RM, Kansas GS, Tedder TF, Furie B, Furie BC. Lectin and epidermal growth factor domains of P-selectin at physiological density are the recognition unit for leukocyte binding. Blood 1995; 85: 151-8.
26. Nagata K, Tsuji T, Hanai N, Irimura T. Role of O-linked carbohydrate chains on leukocyte cell membranes in platelet-induced leukocyte activation. J Biol Chem 1994; 269: 23290-5.
27. Gawaz M, Bogner C. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis. Clin Invest 1994; 72: 424-9.
28. Luscher TF. Platelet-vessel wall interaction: role of nitric oxide, prostaglandins and endothelins. Baillieres Clin Haematol 1993; 6: 609-27.
29. Yan Z, Holt JC, Stewart GJ, Niewiarowski S. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing. Am J Physiol 1993; 265: C1396-404.
30. Power CA, Proudfoot AE, Magnenat E, Bacon KB, Wells TN. Molecular cloning and characterization of a netrophil chemotactic protein from porcine platelets. Eur J Biochem 1994; 221: 713-9.
31. Matsumura Y, Murata S, Takada K, Takaoka M, Morimoto S; Involvement of transforming growth factor-beta 1 for platelets-induced stimulation of endothelin-1 production. Clin Exp Pharmacol Physiol 1994; 21: 991-6.
32. Gross DR. General principles of animal selection, preoperative care, preanesthesia, chemical restraint and analgesia. In: Gross DR. Animal models in cardiovascular research, 2nd ed; Dordrecht/Boston/London: Kluwer Academic Publishers 1994; 1-12.
33. Pond WG. Nutrition and the cardiovascular system of swine. In: Stanton HC, Mersmann HJ. Swine in cardiovascular research, Vol. II, Boca Raton: CRC Press 1986; 2-31.
34. Dubick MA, Kilani AF, Summary JJ, Greene JY, Wade CE. Further evaluation of the effects of 7.5% sodium chloride/6% dextran-70 (HSD) administration on coagulation and platelet aggregation in hemorrhaged and euvolemic swine. Circ Shock 1993; 40: 200-5
35. Hess JR, Dubick MA, Summary JJ, Bangal NR, Wade CE. The effects of 7.5% NaCl/6% dextran 70 on coagulation and platelet aggregation in humans. J Trauma 1992; 32: 40-4.
36. Brandstetter H, Bauer M, Huber R, Lollar P, Bode W. X-ray structure of clotting factor IX a: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci USA 1995; 92: 9796-800.
37. Harvey RB, Kubena LF, Elissalde MH. Influence of vitamin E on aflatoxicosis in growing swine. Am J Vet Res 1994; 55: 572-7.
38. Bakker CM, Blankensteijn JD, Schlejen P, et al. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig HPB Surg 1994; 7: 265-80.
39. Karges HE, Funk KA, Ronneberge H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 1994; 44: 793-7.
40. Lollar P, Parker ET, Fay PJ. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 1992; 267: 23652-7.
41. Lubin IM, Healey JF, Scandella D, Runge MS, Lollar P; Elimination of a major inhibitor epitope in factor VIII. J Biol Chem 1994; 269: 8639-41.
42. Curtis JE, Helgerson SL, Parker ET, Lollar P. Isolation and characterization of thrombin-activated human factor VIII. J Biol Chem 1994; 269: 6246-51.
43. Mashiko H, Takahashi H. Factor XI. purification from porcine plasma by affinity chromatography and some properties of factor XI and activated factor XI. Biol Chem Hopper Seyler 1994, 375: 481-4.
44. Schmaier AH, Danl LD, Hasan AA, et al. Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes. Biochem 1995; 34: 1171-8.
45. Am CM, Carageen JE, Plasmon RR, et al. Mechanismbased isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substitutent in 7-amino-4-chloro-3-(isothiou-reidoalkoxy) isocoumarins on inhibitory and anticoagulant potency. J Med Chem 1994; 37: 1298-306.
46. Spannagi M, Trauner A, Birg A, et al. Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay. Blood Coagul Fibrinolysis 1993; 4: 103-6.
47. Nichols TC, Samama CM, Bellinger DA, et al. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA 1995; 92: 2455-9.
48. Federici AB, Mannucci PM, Fogato E, Ghidoni P, Matturril L. Autopsy findings in three patients with von Willebrand disease type IIB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi. Thromb Haemost 1993; 70: 758-61.
49. Sanders WE Jr, Reddick RL, Nichols TC, Brinkhous KM, Read MS; Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura. Arterioscier Thromb Vasc Biol 1995; 15: 793-800.
50. Radvanyi-Hofmann H, Roussi J, Launary JM, et al. Characterization of a thrombopathy (type delta storage pool disease) affecting a pig colony. Nouv Rev Fr Hematol 1992; 34: 133-40.
51. Schulz E, Ruschitzka F, Lueders S, et al. Effects of endothelin on hemodynamics, prostaglandins, blood coagulation and renal function. Kidney Int 1995; 47: 795-801.
52. Staab DB, Sorensen VJ, Fath JJ, et al. Coagulation defects resulting from ambient temperature-induced hypothermia. J Trauma 1994; 36: 634-8.
53. Apitz-Castro R, Badimon JJ, Badimon L. A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental model. Thromb Res 1994; 75: 243-9.
54. Ueda H, Kobayashi T, Kishimoto M, Tsutsumi T. Okuyama H. EDTA-insensitive deacylation of phosphatidylinositol in porcine platelet membranes. Life Sci 1993; 53: 629-34.
55. Pfliegler G, et-Gamal B, Badimon JJ, Badimon L. Crawford N. Inhibition of platelet recruitment to arterial lesions by predeposition of platelets containing encapsulated iloprost. Thromb Haemost 1994; 72: 604-10.
56. Fletcher MP, Stahl GL, Longhurst JC. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions. Am J Physiol 1993; 265: H1750-61.
57. Smith DJ, Lane TA. Effect of high concentration perflubron emulsion on platelet function. Biomater Artif Cells Immobvilization Biotechnol 1993; 21: 173-81.
58. Thibaudeau K, Anegon I, Lemauff B, Soulillou JP, Blanchard D. Human natural antibodies to porcine platelets. Transplantation 1994; 57: 1110-5.
59. Geller RL, Rubinstein P, Platt JL. Variation in expression of porcine xenogeneic antigens. Transplantation 1994; 58: 272-7.
60. Connolly TM, Condra C, Feng DM, et al. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb Haemost 1994; 72: 627-33.
61. Wilbourn B, Harrison P, Lawrie A, et al. Porcine platelets contain an increased quantity of ultra-high molecular weight von Willebrand factor and numerous alpha-granular tubular structures. Br J Haematol 1993; 83: 608-15.
62. Roussi J, Drouet L, Sigma J, et al. Absence of incorporation of plasma von Willebrand factor into porcine platelet alpha-granules. Br J Haematol 1995; 90: 661-8.
63. Dewanjee MK, Kapadvanjwala M, Ruzius K, et al. Quantitation of thrombogenicity of hemodialyzer with technetium-99m and indium-111 labeled platelets. Nucl Med Biol 1993; 20: 579-87.
64. Dewanjee MK, Kapadvanjwala M, Mao WW, et al. A higher blood flow window of reduced thrombogenicity and acceptable fragmentation in a hollow fiber hemodialyzer. ASAIO J 1993; 39: M363-7.
65. Dewanjee MK, Kapadvanjwala M, Cavagnaro CF, et al. In vitro and in vivo evaluation of the comparative thrombogenicity of cellulose acetate hemodialyzers with radio labeled platelets. ASAIO J 1994; 40: 49-55.
66. Palatianos GM, Dewanjee MK, Panoutsopoulos G, et al. Comparative thrombogenicity of pacemaker leads. Pacing Clin Electrophysiol 1994; 17: 141-5.
67. Qian KX, Wang SS, Chu SH. Haematological variations in pigs during experimental left ventricular assistance with a pulsatile impeller pump. Med Eng Phys 1994; 16: 348-50.
68. Parsson H, Jundzill W, Hallberg E, Thorne J, Norgren L. Acute thrombogenicity and 4 weeks healing properties of a new stretch-ePTFE graft. Eur J Vasc Surg 1993; 7: 63-70.
69. Scott NA, Nunes GL, King SB 3rd, Harker LA, Hanson SR. Local delivery of an antithrombin inhibits platelet-dependent thrombosis. Circulation 1994; 90: 1951-5.
70. Nunes GL, Hanson SR, King SB 3rd, Sahatjian RA, Scott NA. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J Am Coll Cardiol 1994; 23: 1578-83.
71. Parsson H, Cwikiel W, Johansson K, Swartbol P, Norgren L. Depositiion of platelets and neutrophils in porcine iliac arteries after angioplasty and wallstent placement compared with angioplasty alone. Cardiovasc Intervent Radiol 1994, 17: 190-6.
72. Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity. Thromb Haemost 1994; 71: 511-6.
73. Mehri Y, Lacoste LL, Lam JY. Neutrophil implications in platelet deposition and vasoconstriction after deep arterial injury by angioplasty in pigs. Circulation 1994; 90: 997-1002
74. Merhi Y, Lam JY, Lacoste LL, et al. Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. Arterioscler Thromb 1993; 13: 951-7.
75. Meyer BJ, Badimon JJ, Mailhac A, et al. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. Circulation 1994; 90: 2432-8.
76. Meyer BJ, Fernandez-Ortiz A, Mailhac A, et al. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 1994; 90: 2474-80.
77. Moon DG, Matayoshi BM, Weston LK, Minnear FL, Kaplan JE. Fibronectin inhibition of platelet thrombus formation in an in vivo porcine model of vascular injury. Thromb Res 1994; 76: 343-51.
78. Eitzman DT, Chi L, Saggin L, et al. Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4. Circulation 1994; 89: 1523-9.
79. Nunes GL, Thomas CN, Hanson SR, et al. Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation 1995; 92: 1697-700.
80. Mailhac A, Badimon JJ, Fallon JT, et al. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Circulation 1994; 90: 988-96.
81. Scott NA, Robinson KA, Nunes GL, et al. Comparison of the thrombogenicity of stainless steel and tantalum coronary stents. Am Heart J 1995; 129: 866-72.
82. Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radio labeled annexin V on acute porcine left atrial thrombi. Circulation 1992; 92: 3113-21.
83. Tait JF, Cerqueira MD, Dewhurst TA, et al. Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res 1994; 75:491-501.
84. Tait JF, Engelhardt S, Smith C, Fujikawa K. Prourokinaseannexin V chimeras. Construction, expression and characterization of recombinant proteins. J Biol Chem 1995; 270: 21594-9.
85. Johnson CM, Bowie EJ. Pigs with von Willebrand disease may be resistant to experimental infective endocarditis. J Lab Clin Med 1992; 120: 553-8.
86. Zoldhetyi P, Chesebro JH, Owen WG. Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig. Proc Natl Acad Sci USA 1993; 90: 1819-23.
87. Walpoth BH, Ammon A, Galdikas J, et al. Experimental assessment of thrombogenicity in vascular prostheses before and during prostaglandin E1 treatment. Eur J Vasc Surg 1993; 7: 493-9.
88. Thompson JF, Bell R, Bookallil MJ, Sheil AG. Effects of total hepatectomy. studies in a porcine model. Aust NZJ Surg 1994; 64: 560-4.
89. Malmros C, Bolmquist S, Martensson L, Thorne J. lloprost attenuates trauma-related pulmonary sequestration of leucocytes and platelets. Prostaglandins Leukot Essent Fatty Acids 1994; 50: 203-10.